Tammy L. Babinchak, Pharm.D.
Lansdale
Summary
Experienced medical affairs professional with almost two decades in the pharmaceutical sector. Recognized for building resilient stakeholder relationships and executing successful Medical Affairs strategies. Empowers and inspires teams through an intuitive leadership approach that enhances collaboration and performance.
Overview
21
21
years of professional experience
Work History
Sr. Director, Medical Affairs Strategy
CymaBay Therapeutics
05.2023 - 07.2024
- Identified, led, and supported development and execution of key medical affairs strategies across a matrixed and growing organization.
- Developed and cross-functionally aligned a strategic Medical Affairs Plan to ensure the successful launch and lifecycle management of seladelpar.
- Partnered with VP of Medical Affairs, CSO, and internal clinical development colleagues to establish a scientific platform and strategic scientific communication plan.
- Developed, led, and oversaw execution of critical medical affairs and scientific communication strategies, including:
- Strategic publication planning
- Congress planning and execution
- Advisory board planning and execution
- Medical educational program planning and execution
- Evidence generation
- Associated vendor management
- Data dissemination and medical communication plans
- Partnered with appropriate internal teams to ensure all external-facing scientific materials and presentations are strategically aligned, scientifically rigorous, accurate, clinically meaningful and impactful.
- Liaised with clinical development and corporate communications to align communications with data releases.
- Collaborated with MSL Field Director to develop field strategy priorities, development and approval of field resources, and training support to ensure successful field execution and pull through.
- Collaborated with commercial/marketing as subject matter expert, offering medical training, and providing informed recommendations as needed ensuring all activities are adherent to relevant industry regulations.
- Collaborated with clinical development, regulatory, and clinical operations to provide strategic clinical trial input.
- Provided strategic input into investigator-initiated research proposals and expanded access programs.
- Collaborated with IT to ensure successful Veeva Medical Communications platform implementation, followed by successful company-wide launch and utilization for all medical communication materials.
- Chaired legal, medical, and regulatory review (LMRC) committee for all medical communication and field materials.
- Led the implementation of Medical Information Call Center (MICC).
- Collaborated with Regulatory, Quality, Compliance and external vendor to develop SOP for MICC implementation.
- Collaboration with VP of MA for budget, selection of vendor support, training, and full MICC implementation.
- Supported Director of MI to ensure timely and compliant development of SRDs in response to MI requests. of MICC..
- Supported Director of MI to ensure timely and compliant development of SRDs in response to MI requests
- Developed strong relationships with key industry partners, fostering collaboration and mutual growth opportunities.
- Optimized project timelines by effectively delegating tasks and prioritizing workload among team members.
- Developed strong relationships with key industry partners, fostering collaboration and mutual growth opportunities
- Supported VP to ensure an agile working environment, enabling rapid response to changing business needs without sacrificing quality or performance standards.
- Streamlined operations for increased efficiency with process improvements.
- Championed continuous improvement initiatives to drive operational excellence within the organization.
- Drove strategic improvements to enhance operational and organizational efficiencies.
- Enhanced internal communication channels, resulting in improved information flow and decision-making processes.
- Successfully managed Scientific Communications budget and allocated resources to maximize productivity.
- Negotiated favorable contracts with vendors for reduced costs and improved service quality.
- Cultivated positive relationships with vendors to deliver timely and cost-effective supply of services and materials.
- Evaluated MI employee performance and conveyed constructive feedback to improve skills.
- Defined clear targets and objectives and communicated to other team team members within Medical Affairs and across the organization.
- CymaBay Therapeutics was acquired by Gilead in March of 2024; served as a key leader in integration planning for Medical Affairs Strategy, Publications, and Medical Information.
Scientific Director, US Medical Affairs
Merck Research Laboratories
04.2019 - 03.2023
- US field strategy team leader supporting the US Regional Medical Scientific Director (RMSD) field team within Global Medical Affairs.
- Responsible for developing and maintaining close working relationships with key internal stakeholders within highly matrixed organization and across multiple cross-functional teams, including Clinical Sub-teams (CSTs) of the Product Development Teams (PDT), publications teams, Global Clinical Trial Operations (GCTO), Human Health (commercial/sales), and Global Marketing and the leaders within these groups.
- Partnered with Global Scientific Training (GST), Global Scientific Content (GSC), US Global Clinical Trial Organization, (GCTO), Global Medical Scientific Affairs (GMSA) TA lead, and relevant internal and external subject matter experts to consult and assist in the delivery of regional training.
- Served as a key scientific interface between GMSA and HQ functions and the US field.
- Worked closely as a member of the Infectious Diseases Virology and Vaccines (ID/V/V) USMA Leadership Team (LT) and has responsibility for scientific aspects field strategy and execution, including the integrated US Country Medical Plan, including US Field Execution Plan (FEP) and field training plan for assigned therapeutic area.
- Collected, tracked, and communicated scientific insights from US field engagements to inform company strategies, as per the GMSA (therapeutic area) TA needs.
- Enhanced team collaboration through regular communication, establishment of engagement priorities, and performance input to field leadership.
- Actively participated in bi-directional information exchange and sharing of best practices across the various roles and teams in USMA, including Health Systems, to optimize USMA Field execution.
- Collaborated to prioritize Regional Medical Science Director (RMSD) activities to advance Merck research studies (Merck-Investigator Study Program (MISP), company-sponsored trials, and others) in collaborations with GCSA and GCTO.
- Collaborated with the USMA Field Medical Alignment Director to ensure consistent standards, processes, and harmonization for training activities (e.g Clinical immersions, verbalizations, journal clubs, etc.).
- Provided input into strategic congress priorities for USMA and participates in planning of RMSD activities at key scientific congresses; ensured alignment and pull-through of pre- and post-congress regional training and content needs and field execution priorities for the 30/60/90day field execution plan.
- Represented USMA in partnership with GMA and GCSA in implementation of Input forums (SIEs, EIFs, GTEFs or Ad boards).
- Key representative Global Medical Communications Team (GMCT) to discuss and align on strategic context of emerging data, key communication points, probing questions for scientific engagement and training for execution pull through.
- Mentored high-performing teams by providing strategic guidance, and opportunities for improved field engagement.
- Established a culture of continuous improvement by fostering open communication while empowering employees to voice their ideas and concerns regarding data dissemination and KOL perception of the data informing finalized congress posters and oral presentations.
- Cultivated a positive work environment that fostered employee engagement in data trainings and field activity while boosting overall team morale.
- Facilitated cross-functional collaboration for improved decision-making processes within the organization.
- Proactively identified potential risks and offered alternative approaches and/or mitigation strategies to minimize negative impacts of possible data mistranslations.
- In collaboration with Virology leadership team, navigated field organization through periods of significant change, maintaining focus on long-term strategic goals while developing attainable and motivating short-term goals.
- Trained, motivated, and guided team members to maintain high productivity.
- Assisted in recruiting, hiring and training of team members.
- Observed each employee's individual strengths and worked with team leads to mentor and track areas of weakness in engagement and scientific exchange.
Scientific Affairs Strategy and Training Lead
Merck Research Laboratories
03.2016 - 04.2019
- Responsible for developing and maintaining close working relationships with key internal stakeholders within two therapeutic areas (HIV and HCV) within a matrix organization and across multiple cross-functional teams, including clinical sub-teams (CSTs) of the Product Development Teams (PDT), Publications teams, Global Clinical Trial Operations (GCTO), and the leaders within these groups.
- Responsible for developing and maintaining close working relationships with key internal stakeholders within two therapeutic areas (HIV and HCV) within a matrix organization and across multiple cross-functional teams, including clinical sub-teams (CSTs) of the Product Development Teams (PDT), Publications teams, Global Clinical Trial Operations (GCTO), and the leaders within these groups.
- Supervised RSD driven Merck Investigator Studies Program (MISP) to ensure scientifically sound and strategically aligned study proposal submissions to Global Director of Scientific Affairs (GDSA)/MISP chair, as well as identification of data gaps that inform areas of interest for marketed HIV and HCV Merck products.
- Lead the development of RSD congress strategy plan, including RSD and MSL training of Merck data, prioritization of competitor congress data coverage, and analysis and interpretation of the key data that informs the post-congress scientific strategy document.
- Developed content for RSD post-congress debrief trainings to support execution of RSD Field Strategy Plan.
- Development and roll out of quarterly RSD Field Strategy Plan to US Field RSD Team.
- Summary and analysis of investigator field feedback and suggested MRL actionable items, presented monthly at Global Scientific Affairs Team (GSAT) meeting as well as CSTs as requested.
- In collaboration with medical affairs team leadership, development of core field resources to support RSD and MSL (Medical Affairs) field execution.
- Collaborated with GCTO colleagues to support execution of priority Merck sponsored trials through RSD scientific engagement with investigators and research support staff.
- Lead the development and execution of a comprehensive Virology RSD Training Plan.
- Established key internal relationships to elevate RSD role and ensure understanding within MRL, including differentiation of RSD role from similar field-based roles within Merck Global Medical Affairs (GMA) and Global Human Health (GHH).
- Successful integration of the RSD team into key internal teams and coached MSLs within team for field execution and insight collection.
- Worked closely with GDSA to develop annual Scientific Leadership Strategy plan for both HIV and HCV.
- Developed annual RSD Scientific Affairs Plan (SAP) which summarizes relevant strategic insights and field execution plans to further inform future HCV and HIV clinical research within MRL.
- Presented SAP to Executive Senior Leadership Team during end of year planning meetings in 2016 and 2017.
- In close collaboration with GDSA in each respective therapeutic area (HIV and HCV), coordinated RSD efforts, including data trainings, data prioritization, RSD data coverage, and strategic input into Scientific Strategy Document for 2 major congresses in 2016 and 4 major congresses through 2017, and 3 in 2018 to date.
- In collaboration with GDSA, planned, coordinated, and led execution of CROI 2018 SA/MA post-congress debrief.
- Managed budget allocations for multiple training projects, ensuring cost-effective delivery without compromising quality or impact.
- Optimized training resources by conducting regular audits and eliminating redundancy or outdated materials, maintaining a current and effective learning library.
- Oversaw RSD field leader onboarding process for new hires, reducing time to proficiency and increasing employee satisfaction.
- Facilitated effective communication between departments through collaborative workshops, enhancing organizational synergy and productivity.
- Delivered engaging presentations on pre-conference training meetings, guiding RSD positioning of the company as an expert resource in its field.
- Organized informative seminars featuring guest speakers from relevant industries, enhancing employees' knowledge base beyond internal expertise.
- Led cross-functional team training sessions to foster collaboration and improve overall efficiency.
- Provided virtual training and online presentations.
Scientific Director, Global Medical Affairs
Intercept Pharmaceuticals
08.2015 - 02.2016
- One of five internal medical affairs team members responsible for developing, executing, and working cross-functionally to support the Medical Communication Plan and Strategy.
- Self-motivated, with a strong sense of personal responsibility.
- Worked effectively in fast-paced environment.
- Skilled at working independently and collaboratively in a team environment.
- Proven ability to learn quickly and adapt to new situations and manage difficult conversations to improve communication and working environment.
- Facilitated cross-functional collaboration for improved decision-making processes within the organization.
- Implemented innovative solutions to solve complex problems, resulting in increased productivity and streamlined operation.
- Leveraged professional networks and industry knowledge to strengthen client relationships.
- In collaboration with clinical development and biostatistics team, interpreted scientific data and drove medical content and resource development for the entire organization.
- Close collaboration with the Medical Affairs Training Team to ensure effective communication of the Medical Communication Plan and Strategy for successful on boarding and on-going Medical Field Team training needs.
- In conjunction with senior level members of the medical affairs team, supported and helped to execute key components of the medical plan/medical strategy for second half of 2015.
- Medical affairs team representative on internal cross-functional team to develop the PBC commercial platform.
- Medical representative on Competitive Intelligence cross-functional team.
- Commercial/marketing point of contact for medical approval of select commercial/marketing materials.
- Medical representation on Publications Planning Team
- Reviewed and provided commentary on all abstracts, posters, and oral presentations submitted and accepted to AASLD 2015 (15 posters, 2 oral presentations)
- Abstract submission review for AMCP 2016
- Abstract submission planning for EASL 2016
- Developed, presented, and gained medical/legal/regulatory approval of the PBC scientific platform to be used for the development of resources company-wide in preparation for launch and in support of the medical plan.
- Advisory board content review/development for 9 advisory boards (global, national, regional)
- AASLD 2015 Congress Coordination and Planning
- Evaluated and selected vendor support for congress planning.
- Created and managed AASLD cross-functional coverage team who were responsible for initial review of all AASLD abstracts and development of Rapid Response (RR) abstract list.
- Developed RR slide deck which was distributed company-wide within 48 hours of abstract release.
- Managed development of data coverage spreadsheet and made coverage assignments.
- In conjunction with Sr Director of Training, coordinated, developed content, and presented competitive intelligence data for Intercept Global Medical Affairs pre-conference meeting.
- Managed daily data coverage reporting, development of key takeaways and implications to Intercept, daily data summaries, and distribution of the information during AASLD meeting.
- Coordinated, developed content, and moderated ICPT on-site AASLD end of meeting debrief.
- Created, coordinated, and developed content for the inaugural Global AASLD 2015 Spotlight Session.
- Company-wide program incorporating external KOL experts to review and discuss key data selected by Intercept that was presented at AASLD focused on PBC and NASH.
Medical Science Liaison
Intercept Pharmaceuticals
01.2014 - 08.2015
- Territory management including identification and relationship building with thought leaders in primary biliary cirrhosis (PBC) and non-alcoholic steatohepatitis (NASH) within territory.
- Education and presentation of Intercept mission and product pipeline.
- Liaise between external and internal customers regarding investigator initiated research interests on behalf of investigator or sponsored trial.
- Identification and recommendation of clinical research sites for future Phase III/IV clinical trials.
- Advisory Board Development and Moderation: In conjunction with Sr Director, planned, coordinated, developed content and slide deck, executed, and moderated successful inaugural regional advisory board for Intercept (August 2014).
- Served as primary point of contact, fostering strong relationships between internal teams and external partners.
- Lipid Task Force (LTF): MSL representative on company wide cross-functional team charged with strategic planning of future clinical trials, trial design, and protocol development to generate clinically sound data to address concerns and questions regarding lipid changes identified with novel product.
- MSL role specifically focused on providing feedback regarding clinical applicability of protocol and trial design in addition to field insights of identified data gaps.
- MSL Specialty Niche: Competitive Intelligence (CI): responsible for keeping MSL, strategy, commercial, and marketing teams up to date regarding potential competitors and product pipeline.
- Developed and presented CI slide deck to MSL, commercial, and marketing teams (August); responsible for CI coverage at major national and international congresses (AASLD, EASL) including interpretation of data and updating of anticipated timelines for clinical trial start and completion.
- MSL Specialty Niche: Lipids: Developed MSL training modules (Lipids 101, 201, 202) and reference repository.
- Trained MSL, commercial, and marketing teams.
- Coordinated multiple projects simultaneously, ensuring timely completion and alignment with organizational objectives.
- Maintained up-to-date knowledge of industry trends, sharing insights with colleagues to drive continuous improvement efforts.
- Maintained high degree of professionalism at all times, representing organization with integrity in both internal and external interactions.
- Enhanced customer satisfaction by swiftly addressing concerns and providing solutions to various issues.
- Collaborated closely with department heads to identify opportunities for process improvement initiatives.
- Solved conflicts and addressed issues that occurred between the company and external stakeholders.
- Contributed to successful execution of field execution plan through diligent tracking of field engagement milestones and deliverables.
- Collected and analyzed data and feedback to identify opportunities to improve relationship between KOLs, patient advocates, and the company.
- Aided in the development of niche specific training materials, contributing to the ongoing education of team members and improved performance outcomes.
Associate Director, US MSLs
Vertex Pharmaceuticals
05.2013 - 10.2013
- Led a team of 5 MSLs, supervising daily performance as well as training and improvement plans.
- Conducted mid-year evaluations and provided recommendations for professional development.
- Developed agenda, assigned presenters, and facilitated MSL conference call.
- Recommended new ideas for MSL objectives and further integration into 2014 Medical Plan.
- Supervised and supported MSL lead coordinating AASLD 2013; sought and attained approval of director to lead and revise agenda for MSL team post-AASLD training meeting.
- Constructed team training agenda enabling focused meeting supporting the development of consistent, effective, and confident articulation of data.
- Rapidly developed trust and confidence of my team exemplified by spearheading communication initiatives and team building.
- Fostered culture of continuous improvement by encouraging staff to share innovative ideas and providing resources for professional development.
- Prioritized tasks and allocated resources appropriately to keep teams focused and productive.
- Assisted senior leadership in managing all aspects of operations.
- Rapidly and effectively established strong relationships with key industry partners, creating mutually beneficial opportunities for growth and collaboration.
- Improved overall team efficiency by streamlining project management processes and implementing new collaboration tools.
- Assisted in organizing and overseeing assignments to drive operational excellence.
- Successfully managed budgets and allocated resources to maximize productivity and profitability.
- Established team priorities, maintained schedules and monitored performance.
- Evaluated employee performance and conveyed constructive feedback to improve skill.
- Established performance goals for employees and provided feedback on methods for reaching those milestones.
- Defined clear targets and objectives and communicated to other team members.
Sr. Medical Science
Vertex Pharmaceuticals, Medical Affairs
01.2010 - 05.2013
- Develop, coordinate, and execute Regional Management Plan working closely with key opinion leaders (KOLs) within identified territory for the launch of the new direct-acting antiviral (DAA), INCIVEK (telaprevir) for the treatment of hepatitis C.
- Worked in collaboration with colleagues from Medical Affairs, Pharmaceutical Development, and Clinical Operations to support sponsored Phase IV trials.
- Liaise with internal clinical development team to represent and discuss investigator-initiated studies.
- Understand and support key customer's educational and research needs with available resources.
- Provide latest emerging data in response to specific healthcare professional inquiries.
- Regional Advisory Board Medical Affairs representative/MSL presenter/moderator.
- DAA CI (Competitive Intelligence) collaborator on behalf of MSL team.
- Cross-functional TMC-435 war games Field Medical MSL representative.
- Medical Triage Team MSL representative.
- Supervised development of Real-World Transplant Slide Deck.
- MSL DAA CI co-lead 2011.
- AASLD 2012 DAA CI lead.
- EASL 2012 attendee/CI co-lead.
- EASL 2013 attendee/co-lead.
- Conducted ongoing training with field sales personnel to provide up-to-date product knowledge and use.
- Managed complex projects under tight deadlines while maintaining exceptional attention to detail and accuracy.
- Served as a trusted resource for colleagues seeking guidance on clinical matters or industry best practices.
Medical Science Liaison
Hoffman La-Roche/Genentech
04.2006 - 01.2010
- Developed and maintain relationships with thought leaders in Gastroenterology, Hepatology, and Infectious Diseases who are experts in Hepatitis C.
- Working strictly within Genentech policy and SOP, proactively disseminate clinical and scientific information of marketed and virology pipeline compounds in a timely, ethical and customer-focused manner.
- Implement clinical and educational strategies in collaboration with colleagues from Medical Affairs, Pharmaceutical Development, and Clinical Operations to support trials and educational initiatives and to facilitate investigator-initiated studies.
- Understand and support key customer's educational and research needs with available resources.
- Provide latest emerging data in response to specific healthcare professional inquiries.
- Developed, reviewed and edited slide sets for numerous topics/issues for use by colleagues in field.
- AASLD 2008 MSL lead
- DRIVE committee member; Virtual Village committee member.
- Self-motivated, with strong sense of personal responsibility.
- Worked effectively in fast-paced environments.
- Skilled at working independently and collaboratively.
- Proven ability to learn quickly and adapt to new situations.
- Excellent communication skills, both verbal and written.
- Demonstrated respect, friendliness and willingness to help wherever needed.
- Assisted with day-to-day operations, working efficiently and productively with all team members.
- Passionate about learning and committed to continual improvement.
- Managed time efficiently in order to complete all tasks within deadlines.
- Organized and detail-oriented with strong work ethic.
- Used critical thinking to break down problems, evaluate solutions and make decisions.
- Strengthened communication skills through regular interactions with others.
- Adaptable and proficient in learning new concepts quickly and efficiently.
- Proved successful working within tight deadlines and fast-paced environment.
- Developed and maintained courteous and effective working relationships.
- Demonstrated strong organizational and time management skills while managing multiple projects.
ID Clinical Pharmacy Specialist
Temple University Hospital
02.2003 - 04.2006
- Revised and coordinated antimicrobial stewardship program.
- Led and implemented hosptial-wide antimicrobial IV-to-PO switch program.
- Chaired the Antimicrobial Utilization Review (AUR) Subcommittee, and served as the pharmacy representative of AUR at Pharmacy and Therapeutics committee meetings.
- Rounded with the Infectious Diseases multidisciplinary consult team.
- Microbiology laboratory workgroup pharmacy leader.
- Provided medical and pharmacy staff education regarding antimicrobial/antiviral pharmacotherapy, and medication use evaluations of anti-infective drugs.
- Led the revision and re-introduction of the antimicrobial utilization guide.
- Stayed abreast of current trends in clinical pharmacy practice through continuous professional development activities, such as attending conferences and workshops.
- Served as a subject matter expert on various Pharmacy and Therapeutics committees, providing valuable input on drug-related decisions within the organization.
- Improved formulary management by evaluating the safety, efficacy, and cost-effectiveness of medications for potential inclusion or exclusion from hospital formularies.
- Reduced hospital readmissions by conducting thorough medication reconciliations during patient transitions of care.
- Conducted regular audits of clinical pharmacy services to ensure adherence to established policies, procedures, and best practices within the profession.
- Led initiatives to improve antimicrobial stewardship by monitoring antibiotic usage patterns, and recommending targeted interventions for optimal treatment outcomes.
- Assisted in the development and implementation of therapeutic protocols for various disease states, ensuring standardized medication therapy approaches across the organization.
- Facilitated effective communication between physicians, nurses, pharmacists, and other healthcare providers regarding complex pharmaceutical care issues.
- Optimized patient therapy outcomes by providing expert consultation services on complex drug therapies across various medical specialties.
- Developed clinical guidelines for the safe and effective use of high-risk aminoglycosides and unusual antimicrobials.
- Increased patient satisfaction with personalized medication counseling, addressing concerns, and promoting adherence to treatment plans.
- Promoted a culture of continuous improvement by identifying areas for potential enhancement in clinical pharmacy practice, and recommending appropriate solutions.
- Enhanced patient care by developing and implementing comprehensive antimicrobial therapy management plans for patients prior to discharge.
- Mentored and precepted pharmacy residents and students, fostering professional growth and development.
- Developed educational materials regarding common disease states for both patients and staff members within the facility to enhance understanding of the therapeutic options available.
- Collaborated with interdisciplinary healthcare teams to optimize patient outcomes through evidence-based antimicrobial pharmacotherapy recommendations.
- Participated in quality improvement projects aimed at enhancing medication safety within the organization, and reducing adverse drug events among patients.
- Educated patients on possible drug interactions, potential side effects, and optimal methods of administration.
- Advised physicians on how to properly dose aminoglycosides and vancomycin.
- Provided consultations and answered inquiries from patients, healthcare professionals, and physicians regarding HIV drugs, potential side effects, and specified use.
Education
Infectious Diseases Pharmacy Practice Residency -
Oklahoma City VA Medical Center
Oklahoma City, OK01.2001
Doctor of Pharmacy -
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia
Philadelphia, PA05.2000
Bachelor of Science in Pharmacy -
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia
Philadelphia, PA09.1999
Skills
- Motivational leadership
- Strategic planning
- Medical affairs strategy
- Culture transformation
- Verbal and written communication
- Content development
- Creativity and innovation
- Vendor management
Accomplishments
Published author, Your Time is Now: Finding your Passion and the Courage to Pursue It; Difference Press, 2020.
Awards
- Rho Chi Pharmaceutical Honor Society
- One Half Tuition Merit Scholarship, 1995-2000
- Graduated Cum Laude May 15, 2000
- Reward and Recognition Certificate, St. Joseph Mercy Hospital, April 2002
- Certificate of Special Recognition for Results and Teamwork July 2008
- Certificate of Special Recognition for Trust July 2008
- Retention Bonus August 2013
- Silver VOCAP Award in Recognition for the Development of Real World Transplant Slide Deck April 2013
- Silver VOCAP Award in Recognition of Coordination of EASL 2013 May 2013
- Silver VOCAP Award nominated by CI in Recognition of Coordination of EASL 2013
- Promotion to Associate Director May 2013
- Promotion to Associate Scientific Director August 2015
- Intercept Recognition Award for AASLD Coordination and Planning, November 2015
- Merck Inspire Award Recipient for Overall Collaboration and Execution December 2017
- Merck Inspire Award Recipient for Collaboration and Execution of CROI, IAS, HIV Glasgow 2018-2022
Hobbies and Interests
- Merck Health and Wellness Ambassador, SoulFuel Workshop Creator: November 2017
- Intercept Health and Wellness committee Ambassador and Leader
- Development and implementation of Vertex Running Club (VRC); President, January 2013-October 2013.
Magdalene Center for Healing and Holistic Wellness
- Founder and Spiritual Director
- Experiential teacher and creator of The Way of the Magdalene
Timeline
Sr. Director, Medical Affairs Strategy
CymaBay Therapeutics
05.2023 - 07.2024
Scientific Director, US Medical Affairs
Merck Research Laboratories
04.2019 - 03.2023
Scientific Affairs Strategy and Training Lead
Merck Research Laboratories
03.2016 - 04.2019
Scientific Director, Global Medical Affairs
Intercept Pharmaceuticals
08.2015 - 02.2016
Medical Science Liaison
Intercept Pharmaceuticals
01.2014 - 08.2015
Associate Director, US MSLs
Vertex Pharmaceuticals
05.2013 - 10.2013
Sr. Medical Science
Vertex Pharmaceuticals, Medical Affairs
01.2010 - 05.2013
Medical Science Liaison
Hoffman La-Roche/Genentech
04.2006 - 01.2010
ID Clinical Pharmacy Specialist
Temple University Hospital
02.2003 - 04.2006
Infectious Diseases Pharmacy Practice Residency -
Oklahoma City VA Medical Center
Doctor of Pharmacy -
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia
Bachelor of Science in Pharmacy -
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia